SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-000289
Filing Date
2024-01-03
Accepted
2024-01-03 07:00:18
Documents
14
Period of Report
2024-01-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20240102_8k.htm   iXBRL 8-K 28822
2 EXHIBIT 99.1 ex_611509.htm EX-99.1 15115
  Complete submission text file 0001437749-24-000289.txt   196544

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20240103.xsd EX-101.SCH 3848
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20240103_def.xml EX-101.DEF 13379
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20240103_lab.xml EX-101.LAB 17543
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20240103_pre.xml EX-101.PRE 13356
8 EXTRACTED XBRL INSTANCE DOCUMENT bcda20240102_8k_htm.xml XML 4245
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 24504328
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)